6. Anti-fungal and Anti-protozoal Agents Flashcards
Classification of anti-fungal drugs
- Drugs for subcutaneous and systemic mycotic infection
2. Drugs for cutaneous mycotic infections
Types of drugs for subcutaneous and systemic mycotic infection
- Amphotericin B
- Antimetabolite antifungals: Flucytosine
- Echinocandins: Caspofungin
- Azole antifungals: Triazoles
Types of drugs for cutaneous mycotic infection
- Nystatin
- Squalene epoxidase inhibitors: Terbinafine
- Azole antifungals: Imidazoles
MOA of amphotericin B
Binds to ergosterol in the plasma membrane of sensitive fungal cells → forms pores (channels) → disrupts membrane functions → allowing electrolytes (particularly potassium) and small molecules to leak from the cell → cell death
→ fungicidal or fungistatic depending on the organism and the conc. of the drug
Indications for amphotericin B
- Candida albicans (candidiasis)
- Histoplasmosis
- Crpytococcus neoformans
- Aspergillus (Aspergillosis)
Adverse effects of amphotericin B
- Fever and chills
- Nephrotoxicity
- Hypotension
- Thrombophlebitis
- Bone marrow suppression
- Ototoxicity
MOA of 5-Flucytosine
5-Flucytosine enters the fungal cells through cytosine specific permeases and is then converted, by cytosine deaminase, to its metabolically active form 5-Fluorouracil (5-FU)
- Conversion of 5-FU into 5-fluorouridine triphosphate (FUTP). FUTP is incorporated into fungal RNA in place of uridylic acid; and inhibits protein synthesis
- Metabolism of 5-FU into 5-fluorodeoxyuridine monophosphate (FdUMP), a potent inhibitor of thymidylate synthase, which is a key enzyme of DNA synthesis
→ fungistatic
Indications for 5-Flucytosine
effective in combination with amphotericin B for treating candidiasis and cryptococcosis (meningitis and pulmonary infections)
Resistance to 5-Flucytosine
Decreased levels of any of the enzymes in the conversion of 5-FC to its metabolites and/or development of an increased synthesis of cytosine during therapy → not used as a single antimycotic drug, used in combination with amphotericin B which allows more 5-FC to penetrate the cell thus leading to synergistic anti-fungal effects and minimises resistance
Adverse effects of 5-Flucytosine
- GI effects
- Bone marrow suppression
- Hepatotoxicity
Types of Echinocandins
- caspofungin
- micafungin
- anidulafungin
MOA of Echinocandins
Inhibit the activity of the glucan synthase complex → loss of structural integrity of the cell wall
Indications for Echinocandins
- First-line option for invasive candidiasis, including candidemia
- Second-line option for aspergillosis (for those who have failed or cannot tolerate amphotericin B or an azole)
Adverse effects of Echinocandins
- GIT related symptoms
- Fever
- Chills
- Rashes
- Skin flushing
- Thrombocytopenia
Types of triazoles
- Fluconazole
- Itraconazole
- Voriconazole